1. Home
  2. ITRM vs EQS Comparison

ITRM vs EQS Comparison

Compare ITRM & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.47

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Logo Equus Total Return Inc.

EQS

Equus Total Return Inc.

HOLD

Current Price

$1.80

Market Cap

25.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITRM
EQS
Founded
2015
1991
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
24.3M
25.8M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ITRM
EQS
Price
$0.47
$1.80
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
1.3M
5.2K
Earning Date
11-14-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$390,000.00
$1,377,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$325.95
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
21.11
52 Week Low
$0.36
$0.74
52 Week High
$3.02
$2.49

Technical Indicators

Market Signals
Indicator
ITRM
EQS
Relative Strength Index (RSI) 45.29 45.22
Support Level $0.40 $1.77
Resistance Level $0.50 $1.90
Average True Range (ATR) 0.06 0.11
MACD 0.01 -0.00
Stochastic Oscillator 58.91 31.43

Price Performance

Historical Comparison
ITRM
EQS

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About EQS Equus Total Return Inc.

Equus Total Return Inc is a United States-based closed-end management investment company. It invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.

Share on Social Networks: